BSX Q2 2020 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.0B-23.9% YoY

Gross Profit

$987M49.3% margin

Operating Income

-$61M-3.0% margin

Net Income

-$147M-7.3% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-21.2%

Cash Flow

Operating Cash Flow

$269M

Free Cash Flow

$174M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$30.8B

Total Liabilities

$15.2B

Stockholders' Equity

$15.6B

Cash & Equivalents

$1.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.0B	$2.6B	-23.9%
Gross Profit	$987M	$1.7B	-41.8%
Operating Income	-$61M	$431M	-114.2%
Net Income	-$147M	$154M	-195.5%

Revenue Segments

Cardiovascular

$834M59%

MedSurg

$576M41%

Geographic Segments

UNITED STATES

$1.1B56%

Non-US

$885M44%